Boldenone

What it is

Boldenone undecylenate is an androgen licensed for veterinary use, principally in horses. Structurally it is testosterone with an added double bond, which slows aromatisation. It has never been approved for human medicine, and its long-acting ester means it clears very slowly.

What’s claimed

• Slow, steady lean gains with minimal water retention
• Marked increase in appetite
• Improved vascularity and endurance

What the evidence shows

The anabolic effect is established in horses, not people (Bronze, animal basis). The appetite increase is the most consistently reported subjective effect and is plausible for an androgen, but is not established in controlled human work. The endurance claim, supposedly via increased red cell production, is the same mechanism that raises haematocrit, which is a cardiovascular risk rather than a benefit.

The risks

• Haematological: a pronounced rise in red cell count and haematocrit, thickening the blood and raising clotting risk.
• Endocrine: suppression of the body's own testosterone production, with testicular atrophy and impaired fertility. Recovery is not guaranteed and can be slow or incomplete.
• Lipids: marked lowering of HDL ('good') cholesterol and raising of LDL, an adverse cardiovascular shift that is more pronounced with oral compounds.
• Oestrogenic: boldenone does aromatise, so gynaecomastia and fluid retention remain possible despite the 'dry' reputation.
• Product risk: manufactured outside any regulatory system. Independent testing repeatedly finds these products mislabelled, under- or over-concentrated, or containing entirely different active drugs, so the real exposure is unknowable from the label.

What needs monitoring

• Full blood count, including haematocrit and haemoglobin
• Lipid profile
• Blood pressure
• Liver and kidney markers
• Testosterone and the wider hormonal axis: a doctor is the right person to arrange these tests and to interpret what they show.